Intellia Therapeutics, Inc. (NTLA)
NASDAQ: NTLA · Real-Time Price · USD
9.52
-2.80 (-22.73%)
At close: Nov 7, 2025, 4:00 PM EST
9.53
+0.01 (0.10%)
After-hours: Nov 7, 2025, 7:59 PM EST

Intellia Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
57.5357.8836.2852.1233.0557.99
Upgrade
Revenue Growth (YoY)
33.52%59.55%-30.40%57.69%-43.01%34.55%
Upgrade
Cost of Revenue
409.88466.31435.07419.98229.81150.41
Upgrade
Gross Profit
-352.35-408.43-398.79-367.86-196.75-92.41
Upgrade
Selling, General & Admin
126.38125.83116.590.3171.144.17
Upgrade
Operating Expenses
126.38125.83116.590.3171.144.17
Upgrade
Operating Income
-478.73-534.26-515.29-458.16-267.85-136.58
Upgrade
Interest & Investment Income
33.3547.8149.838.541.282.35
Upgrade
Earnings From Equity Investments
---15.63-11.08-1.33-
Upgrade
EBT Excluding Unusual Items
-445.38-486.46-481.09-460.7-267.89-134.23
Upgrade
Gain (Loss) on Sale of Investments
-0.43-32.57----
Upgrade
Other Unusual Items
---0.1-13.49--
Upgrade
Pretax Income
-445.81-519.02-481.19-474.19-267.89-134.23
Upgrade
Net Income
-445.81-519.02-481.19-474.19-267.89-134.23
Upgrade
Net Income to Common
-445.81-519.02-481.19-474.19-267.89-134.23
Upgrade
Shares Outstanding (Basic)
1059989777156
Upgrade
Shares Outstanding (Diluted)
1059989777156
Upgrade
Shares Change (YoY)
9.22%11.35%15.33%8.57%26.63%18.50%
Upgrade
EPS (Basic)
-4.25-5.25-5.42-6.16-3.78-2.40
Upgrade
EPS (Diluted)
-4.25-5.25-5.42-6.16-3.78-2.40
Upgrade
Free Cash Flow
-412.63-354.66-408.07-346.85-237.79-53.5
Upgrade
Free Cash Flow Per Share
-3.94-3.59-4.60-4.51-3.35-0.96
Upgrade
Gross Margin
------159.35%
Upgrade
Operating Margin
-832.16%-923.10%-1420.51%-879.04%-810.37%-235.51%
Upgrade
Profit Margin
-774.94%-896.77%-1326.51%-909.78%-810.49%-231.46%
Upgrade
Free Cash Flow Margin
-717.27%-612.78%-1124.94%-665.46%-719.41%-92.25%
Upgrade
EBITDA
-466.25-523.98-506.32-450.59-260.96-130.27
Upgrade
EBITDA Margin
------224.63%
Upgrade
D&A For EBITDA
12.4710.298.987.576.896.31
Upgrade
EBIT
-478.73-534.26-515.29-458.16-267.85-136.58
Upgrade
EBIT Margin
------235.51%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q